(Q30585736)

25 June 2017

1 reference

title

The contribution of magnetic resonance imaging in the differential diagnosis of the damage of the cerebral hemispheres (English)

1 reference

25 June 2017

Grossman RI

1

1 reference

25 June 2017

Kappos L

series ordinal

2

1 reference

25 June 2017

Wolinsky JS

series ordinal

3

1 reference

25 June 2017

publication date

1 January 2000

1 reference

Journal of the Neurological Sciences

25 June 2017

published in

1 reference

25 June 2017

volume

172 Suppl 1

1 reference

25 June 2017

page(s)

S57-62

1 reference

Axonal transection in the lesions of multiple sclerosis

25 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Axonal damage in acute multiple sclerosis lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Effect of interferon-beta1b on magnetic resonance imaging outcomes in secondary progressive multiple sclerosis: results of a European multicenter, randomized, double-blind, placebo-controlled trial. European Study Group on Interferon-beta1b in secon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Relapsing-remitting multiple sclerosis: longitudinal analysis of MR images--lack of correlation between changes in T2 lesion volume and clinical findings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Major differences in the dynamics of primary and secondary progressive multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Proton magnetic resonance spectroscopy in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Proton MRS of gadolinium-enhancing MS plaques and metabolic changes in normal-appearing white matter.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Corpus callosum in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

The distribution of plaques in the cerebrum in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Decline of cognition in multiple sclerosis: dissociable deficits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Cranial computed tomography in the diagnosis of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

CT and EEG investigations in 100 patients with multiple sclerosis (MS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Computerized tomography of brain and optic nerve in multiple sclerosis. Observations in 100 patients, including serial studies in 16

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Computer tomography of the cerebrum in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Chronic progressive multiple sclerosis. Relationship between cerebral ventricular size and neuropsychological impairment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Computerized tomography in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Automated measurements of cerebral atrophy in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Brain magnetic resonance imaging correlates of cognitive impairment in multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

White matter lesions and cognitive deficits: relevance of lesion pattern?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Multiple sclerosis and corpus callosum atrophy: relationship of MRI findings to clinical data.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Magnetic resonance imaging and clinical correlations in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Cerebral disconnection in multiple sclerosis. Relationship to atrophy of the corpus callosum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Progressive cerebral atrophy in multiple sclerosis. A serial MRI study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Quantitative multiple sclerosis plaque assessment with magnetic resonance imaging. Its correlation with clinical parameters, evoked potentials, and intra-blood-brain barrier IgG synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: Implications for clinical trials and natural history

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Multiple sclerosis: A serial study using MRI in relapsing patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Benign versus chronic progressive multiple sclerosis: magnetic resonance imaging features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Serial gadolinium-enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Serial magnetic resonance scanning in multiple sclerosis: a second prospective study in relapsing patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Neuropsychological assessment in patients with relapsing-remitting multiple sclerosis and mild functional impairment: correlation with magnetic resonance imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Magnetic resonance imaging correlates of dementia in multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Neuropsychological and structural brain lesions in multiple sclerosis: A regional analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Magnetic resonance relaxation time mapping in multiple sclerosis: normal appearing white matter and the "invisible" lesion load

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

A Magnetization Transfer Imaging Study of Normal-Appearing White Matter in Multiple Sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Inter- and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke Expanded Disability Status Scale (EDSS). Multiple Sclerosis Collaborative Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Scales for rating impairment in multiple sclerosis: a critique.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Multiple sclerosis: gadolinium enhancement in MR imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

The site of the lesion causing deafness in multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Quantitative MR in the diagnosis of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with primary progressive multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Quantitative volumetric magnetization transfer analysis in multiple sclerosis: estimation of macroscopic and microscopic disease burden.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Correlation of volumetric magnetization transfer imaging with clinical data in MS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

High resolution proton NMR spectroscopy of multiple sclerosis lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Human brain proton localized NMR spectroscopy in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

Multiple sclerosis: assessment of disease progression and effects of treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900281-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-510X(99)00281-6

1 reference

release_bjmxorqlrbacjct2tfdjwfbui4

25 June 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bjmxorqlrbacjct2tfdjwfbui4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference